chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Migraines; Obscured vision, difficulty reading; This is a spontaneous report from a contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the arm right on 07Apr2021 at 12:45 (at the age of 20-year-old) and received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the arm right on an unknown date in 2021 (at the age of 20-year-old) both as a single dose for COVID-19 immunisation. The patient did not have any medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any concomitant medication within two weeks prior to the vaccination. On 14Apr2021 at 10:00, the patient experienced migraines almost daily, obscured vision and reading difficulty. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events migraines almost daily, obscured vision and reading difficulty was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
fever of 102 degrees, chills, fatigue, nausea.  All symptoms lasted about 18 hours after onset.
Was fine after the first two doses.  a week after the booster - leg, foot and ankle pain in muscle and joints.  Still continuing despite RX treatments.  No Causal factor of sudden onset except for the booster.   Also will report in Vsafe.  Though it may be related to the vaccine after reading information.
Sore throat, plugged sinuses, body aches & pains, low grade temp, cough, chest pain, ear infect; treated as a cold w/juices, vit C cold meds & ATB prescribed by MD;
dizziness; felt stiff; This is a spontaneous report from a contactable consumer.  A male patient in the 90's received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration from an unspecified date to an unspecified date at SINGLE DOSE for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  The consumer reported that she is reporting about her friend. He got his first covid vaccine and afterwards experienced dizziness on unspecified date. He also did yard work for about 6 hours felt stiff so he took some acetaminophen and oxycodone (PERCOCET) and she wonders if that could have interfered with the vaccine effectiveness. The consumer was asking if taking acetaminophen and oxycodone after getting the covid vaccine will nullify the vaccine. Outcome of the events was unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
SORENESS/SHARPNESS-PAIN ON DEEP INSPIRATION, NO SENSITIVE TO TOUCH, OVER THE KIDNEY AREA.  NO PAIN ON EXHALING.  PAIN DECREASED OVER THE NEXT 30 DAYS.  NO DOCTOR OR HOSPITAL VISIT.  NO PROBLEMS TODAY WHEN INTERVIEWED.
Seen in ED 10/28/2016 for weakness in legs, admitted to Hospital 10/29/16 from ED. Admit note: 68yoF who presented with leg weakness. About 2 weeks ago, the patient received a flu shot. She then developed URI symptoms and treated with Z-pack as an outpatient. Over the past 2 weeks, she says that her legs have been progressively weaker. She used to be ambulatory with a cane and able to walk around and perform ADLs such as walking to the mailbox. Now, she says her legs are so weak that she needs help even with minimal ambulation. She was seen by her PCP yesterday for the leg weakness, who sent her to the ED. Aside from the bronchitis/URI, she had been otherwise well. No N/V, HA, diarrhea, fever, chills, dysuria, CP, SOB. She has not had any recent travel nor known sick contacts. 10/13/16 flu shot, Post flu shot note by Dr: He felt that she had Guillain-Barre syndrome. He recommended IVIG. The patient received 5 doses of IVIG. Was in hospital til 11/3/16 but had fistulogram during this admit because she is dialysis pt.
Pt called on 1/3/2021 to report that after receiving her vaccine on 12/31/2020, she began to experience nausea and lack of appetite. No additional side effects or symptoms reported. No vomiting. Pt able to drink fluids and stay hydrated.
Pt received vaccine on 4/1/21. On Sunday, 4/4/21, pt started to have muscle cramps in thighs and all down legs.  Were so severe at times she couldn't walk.  Muscle cramps subsided by 4/6/21 and pt noticed a knot on each inner thigh.  Patient is concerned about the knots and if they may cause a blood clot.
Facial numbness and tingly sensation that began in the chin and jaw area a few days after the 2nd dose. A week and a half later, the tingly sensation spread to the lips, cheeks and forehead. I am still experiencing this.
Skin Rash - after 1 week of vaccination. Extreme tiredness muscle ache and joint pain. Pt has Leukocytoclastic vasculitis gene before the 3 vaccines. Adverse event lasted for over a month.
Injection site soreness; Headache; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ENG206) via an unspecified route of administration in the right arm on 04Mar2021 at 17:15 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included acetylsalicylic acid/caffeine/salicylamide (BC powder). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04Mar2021 at 20:00, the patient experienced injection site soreness and headache. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the adverse events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site soreness and headache was not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
FEVER OF 100.6, fatigue, headache, muscle pain, joint pain. chills NO nausea and NO vomiting
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Nurse). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Apr2021 as dose 2, single (Batch/Lot number: unknown) at the age of 45 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Iodine" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the current available limited information in the case provided, the causal association between the events and the use of suspect product BNT162B2 cannot be fully excluded.
about 10 minutes into his waiting period, I noticed he laid his head on his dad's shoulder. I went to check on him and he said he did not feel right. he described feeling dizzy and trouble seeing. I got him water, ice pack and took his blood pressure and used a pulse oximeter. His BP was 90/50 and hr was in the 50's o2  were perfect. we continued to monitor his and told him to drink more water. (he consumed 2 small bottles) before he left (30 minutes later) he was feeling much better. His dad said he was very nervous and has done this before with injections.
Initial information received on 26-Jul-2018 regarding an unsolicited valid non-serious case received from a Nurse. This case is linked with 2018SA207851, 2018SA208858, and 2018SA208860 (same reporter). This case involves a 18 months old patient (unknown gender) who was vaccinated 0.5 ml fourth single dose expired dose of vaccine ACT-HIB lot UI719AAA (expiry date: 18-Oct-17), in the left thigh on 10-Jan-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS A VACCINE; PREVNAR 13; MMR vaccine, DAPTACEL and VARICELLA ZOSTER VACCINE. It was a case of actual medication error due to expired vaccine used. It was unknown whether patient experienced any adverse event to product. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: None.
Heart problems caused by Pfizer vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CARDIAC DISORDER (non-serious), outcome "unknown", described as "Heart problems caused by Pfizer vaccine".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT REPORT OF HEACHE, INJECTION SIDE TENDER AND WARM TO TOUCH. REACTION STARTED DAY AFTER INJECTION. HER TEMP WAS 97.0 WHEN SHE REPORTED IT AND I COULDNT SEE ANY VISIBLE SWOLLEN AT THE SITE. I INFORMED THE PATIENT TO REACH OUT TO HER DOCTOR OR SEEK MEDICAL ATTENTION FROM URGENT CARE. I ALSO INFORMED HER TO TAKE TYLENOL FOR THE PAIN AND  USE ICE PACK AT THE SITE OF INJECTION
Patient states she had itching all over body after the vaccination. She has never had a reaction before.
I did not have an adverse reaction to the vaccine. I was exposed to COVID-19 from my husband. I had a runny nose and a slight cough. Two days later, I tested positive for COVID-19 on 11/30/2022. I mainly had cold like symptoms. I took over the counter medications to help with my symptoms. As of today, I do not have any lingering COVID-19 symptoms.
Slight headache; Muscles hurt; Not feeling well; Body aches; My arm where they shot me, I cannot move it, it hurts so bad; My arm where they shot me, I cannot move it, it hurts so bad; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 08Jun2021 (Lot number: EW0180) at the age of 50 years as dose 2, single for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (first dose), administration date: 18May2021, when the patient was 50 years old, for COVID-19 immunization. The following information was reported: HEADACHE (non-serious) with onset 08Jun2021, outcome "unknown", described as "Slight headache"; MYALGIA (non-serious) with onset 08Jun2021, outcome "unknown", described as "Muscles hurt"; MALAISE (non-serious) with onset 08Jun2021, outcome "unknown", described as "Not feeling well"; PAIN (non-serious) with onset 08Jun2021, outcome "unknown", described as "Body aches"; MOVEMENT DISORDER (non-serious), PAIN IN EXTREMITY (non-serious) all with onset 08Jun2021, outcome "unknown" and all described as "My arm where they shot me, I cannot move it, it hurts so bad". Therapeutic measures were taken as a result of headache, myalgia, malaise, pain, movement disorder, pain in extremity.  Additional information: Treatment received was Tylenol.  No follow-up attempts are possible. No further information is expected.
Sore arm muscles, nausea, stomach pain, overall muscular pain in body.  In general, I do not  feel well at all.   I have taken 2 aleve pills to try and see if it will help.  So far I do not notice any relief.
Patient came in for a Nurse Visit for her 4-year-old immunizations.  With the help of an interpreter, I verified with the parent that her child was here to get DTaP, Polio, MMR, Varicella, and a flu shot.  Parent said yes.  When the child was scheduled for a Nurse Visit, it just said "4 year old imms".   I highlighed the immunizations needed on the paper - DTaP, Polio, MMR, Varicella, and I accidently highlighted Influenza.  Since this is still the beginning of the flu vaccine season, I highlighted Influenza in error.  I drew up the vaccines, had them verified by another medical assistant, and administered them to the patient.  It wasn't until I went to document the immunizations that I realized the patient had already had an influenza vaccine on 9/23/2022.  I alerted my supervisor and informed the parent that I accidently gave the child an extra flu shot for the season.  I informed the parent that her child might be a little extra sleepy.  I encouraged her to call us if her child has any negative reactions to the extra vaccine.
Patient started feeling dizzy after vaccination and fell when trying to stand up and leave the vaccination room. Paramedics were called immediately. pharmacist and technician on duty helped patient get up from the floor and checked his vitals while having  him seated. Blood pressure was 112/48 , heart rate at 63. His eyes were having trouble focusing for a few seconds and was complaining about being cold. He was given bottled water and blanket.  The paramedics arrived within 10 minutes, rechecked his vitals and blood sugar, monitored for dizziness symptoms and patient improved significantly after about 15 minutes. Paramedics declared that patient was safe to drive himself home.
The pneumonia vaccine was administered by a nurse's assistant. I experienced intense pain the next day and then itching in the area for 1 week.
Hives with itching started morning 1-2-12 significantly worsened after shower in evening; hives spread from arms to legs, abdomen, back, above eyes, below chin. Itching severe enough to keep awake at night. Bruise also noted to (L) arm 40mm x 35mm on morning 12-30-11.
This spontaneous report as received from a medical assistant, refers to a patient of unknown age and gender. No pertinent medical history, drug reactions/ allergies or concurrent conditions were reported.  On an unknown date, the patient was vaccinated with an improperly stored VAQTA (which had a lot # of R003739 and an expiration date of 16-MAR-2019; however, dose, dosage number and route of administration were not reported), for prophylaxis. Nonetheless, no adverse effects were reported. The vaccine experienced the following temperature excursion on an unknown date: below 32F°/ 0°C (-1.2C) for 21 hours. Reportedly, there had been no previous temperature excursions and the aforementioned one was identified due to a data logger. Furthermore, no product quality complaint was involved.; Sender's Comments: US-009507513-1807USA006219: US-009507513-1807USA006220: US-009507513-1807USA000939: US-009507513-1807USA006217: US-009507513-1807USA006218:
The injection site was ok at first but on Nov. 2nd I woke up in the middle of the night with my whole arm extremely painful.  Can barely lift my left arm, have been taking Tylenol but it does not relief the pain.
VARIVAX 2nd dose given on 1-31-11. Pt's mom called clinic today 2-2-11 stating welt 10cm x 15cm where VARIVAX shot given. Site is raised & warm.
About 17 hours after the shot I experienced nausea , vomiting, chills and aches.  This last for about 24 hours.  I still feel weak but am better.
Information has been received from a Licensed Practical Nurse referring to an unspecified number of patients of unknown age and gender. Between 19-MAR-2016 and 10-APR-2016, these patients were vaccinated with improperly stored doses in VARIVAX (Merck) (lot # reported as L043622, expiration date 03-NOV-2017, dose and route were not reported. Previous temperature excursion was reported as first excursion: -4.4C for 40 hours and second excursion: -3.8C for 17 hours. The vaccine was also stored in 0.9C for 20 hours. Digital data logger was used. No adverse effects were reported. Additional information has been requested.
Pt. came back to pharmacy 2 days after administration with a 2 in. red, hot circle at site of injection. Pt. was told to put hydrocortisone/BENADRYL on it and call MD if gets worse.
This case was reported by a other health professional and described the occurrence of injection site erythema in a adult female patient who received Flu QIV. On an unknown date, the patient received Flu QIV (unknown). On an unknown date, an unknown time after receiving Flu QIV, the patient experienced injection site erythema. The patient was treated with ZYRTEC. On an unknown date, the outcome of the injection site erythema was recovered/resolved. It was unknown if the reporter considered the injection site erythema to be related to Flu QIV. Additional information received on 14 November 2014: The patient experienced redness at the injection site, described as wider spread than expected. It was unknown if the patient received FLUARIX QIV or FLULAVAL QIV. Follow-up information received on 25 November 2014: The reporter information was updated. This is one of the 2 cases reported by the same reporter for the same vaccine.
nausea, hot flashes were noted, pt BP 162/98; Spo2 98%; HR 69. Pt given water and waited for extended period. Pt stated she felt better and was able to ambulate independently. A/O x4
Severe ringing in ears (tinnitus) since the day after 2nd dose. Causing headache and some dizziness
Patient experienced side effects after both of his Moderna vaccines. Side effects included flu-like symptoms and lethargic.
This case was reported by a pharmacist via call center representative and described the occurrence of muscle pain in a 60-year-old male patient who received SHINGRIX (batch number AS9CM, expiry date 25th April 2020) for prophylaxis. Previously administered products included SHINGRIX with an associated reaction of myalgia (For tolerance to the 1st dose received on 20th March 2018, refer case US2018GSK149449). On 1st June 2018, the patient received the 2nd dose of SHINGRIX. On 2nd June 2018, 1 days after receiving SHINGRIX, the patient experienced muscle pain, nausea, vomiting and fatigue. On 5th June 2018, the outcome of the muscle pain, nausea, vomiting and fatigue were recovered/resolved. It was unknown if the reporter considered the muscle pain, nausea, vomiting and fatigue to be related to SHINGRIX. Additional details were provided as follows: The next day after vaccination, the patient experienced muscle pain, fatigue, nausea, and vomiting. The events were resolved after 3 days.
we gave Pt Moderna Covid-19 Vaccine,instead of half a dose (0.25mL) we gave a  Full dose (0.5ml) . We called Patient and  he is doing fine.
administration of vaccine was given while patient was sitting and administrator was standing.  the height and angel appear to have hurt the arm which has since caused severe pain, numbness /tingle in fingers of right arm
Injection site arm swelling from shoulder to elbow. Patient went to doctor to seek treatment and received a steroid injection to reduce swelling.
2/13 nickel size reddened area @ injection site, 2/14 area 5cmX5cm in size, Reddened, warm to touch pt complained of itching to area. 2/15  4 small raised areas within large reddened area.  Elocon cream applied.
lmpropely stored vaccine administered; This spontaneous report was received from a nurse referring to a 4 years old male patient. The patient's medical history, concomitant medications, drug allergies, or reactions were not reported.    On 04-AUG-2021, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) lot # T002847 that has been verified to be valid, expiration date 23-JAN-2022,  (number of previous doses was reported as 1; frequency and strength were not reported) intramuscularly in left thigh for prophylaxis (product storage error). The digital data logger was involved to capture the temperature excursion.
Skin rash. Did not go away with oral or topical steriods. Spread to all over body (torso, arms, legs, neck, chest, shoulders, buttocks). Antihistamine regime added (Allegra, Zyrtic, pepcid)  Punch Biopsy showed hives. Diagnosed Chronic Ideopathic Uticaria as a result  Sent to Allergist/immunologist. Prescribled Xolair.  Currently on antihistamines and once a month injection of Xolair.
Received my first vaccine on December 23, 2020 and my second on January 13, 2021. Typical symptoms associated with the vaccine. Entered a research study on 3/15/2021 with a panel of labs drawn for the study. Hep C antibodies came back positive at 6.91. RNA (viral load) was negative. Donated blood at the end of November 2020. No risk factors. Saw a hepatologist (I'm a nurse in a hospital), who told me it was a false positive. Repeat labs were drawn. Viral load negative. Antibodies positive at 6.08. She suggested I submit this paperwork due to the immune response cross reacting with my labs. May not be due to this vaccine specifically but fits the timeline of my vaccine and immune response to COVID-19. All other lab work (Hep B, HIV, etc.) were negative (expected lab results).
9 days after vaccination developed a red mark at the site of injection, progressively  getting one red streak down her arm, purple pupura down both arms
Fever 101, joint pain, pain in the left arm and what caught my attention is a ball between the chest and the left armpit of half an inch in diameter when I touch it I hurt a little
Patient noted tenderness on plantar surface on feet on 5-21-08. On 5-22-08, tenderness increased and rash noted on feet, palms, then extended to legs and arms. By 5-23-08, rash covered most of body, slightly pruritic and causing burning sensation. Urgent care visit - Methoprednisolone 21 pack& Claritin. 5-27-08, PCP visit for steroid injection.